136 related articles for article (PubMed ID: 34375974)
1. Preliminary Study on Apoptotic Proteins in Platelet from Adult Patients with Chronic Immune Thrombocytopenic Purpura.
Xu D; Xie L; Zhang Z; Yu W; Qiu J; Xu CW; He C; Xu X; Cai X; Yi J; Yin J
Acta Haematol; 2022; 145(3):318-325. PubMed ID: 34375974
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis in platelets from adult patients with chronic idiopathic thrombocytopenic purpura.
Xie L; Xu DM; Cai XJ; Zhang ZW; Yu WJ; Qiu JF; Xu CW; He CL; Xu XR; Yin J
Blood Coagul Fibrinolysis; 2021 Oct; 32(7):434-442. PubMed ID: 34102655
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia.
Qiao J; Liu Y; Li D; Wu Y; Li X; Yao Y; Niu M; Fu C; Li H; Ma P; Li Z; Xu K; Zeng L
Immunol Res; 2016 Apr; 64(2):604-9. PubMed ID: 26712345
[TBL] [Abstract][Full Text] [Related]
4. Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia.
Deng G; Yu S; Li Q; He Y; Liang W; Yu L; Xu D; Sun T; Zhang R; Li Q
Hematology; 2017 Apr; 22(3):155-161. PubMed ID: 27734765
[TBL] [Abstract][Full Text] [Related]
5. Role of Ca
Xu DM; Zhang ZW; Yi JX; Xie L; Yu WJ; Qiu JF; Xu CW; He CL; Xu XR; Yin J
Int J Gen Med; 2022; 15():2119-2125. PubMed ID: 35237072
[TBL] [Abstract][Full Text] [Related]
6. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Investigation about the Expression of G Protein-Coupled Receptors in Platelets from Patients with Chronic Immune Thrombocytopenic Purpura.
Xu D; Xie L; Zhang Z; Wang D; Qiu J; Yu W; Xu C; He C; Xu X; Yin J
Acta Haematol; 2021; 144(5):551-559. PubMed ID: 33849009
[TBL] [Abstract][Full Text] [Related]
8. Increased GPIbα shedding from platelets treated with immune thrombocytopenia plasma.
Wei G; Luo Q; Wang X; Wu X; Xu M; Ding N; Zhao Y; Zhong L; Wang J; Wu Y; Li X; Liu Y; Ju W; Li Z; Zeng L; Xu K; Qiao J
Int Immunopharmacol; 2019 Jan; 66():91-98. PubMed ID: 30445311
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
Catani L; Fagioli ME; Tazzari PL; Ricci F; Curti A; Rovito M; Preda P; Chirumbolo G; Amabile M; Lemoli RM; Tura S; Conte R; Baccarani M; Vianelli N
Exp Hematol; 2006 Jul; 34(7):879-87. PubMed ID: 16797415
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of apoptosis-associated proteins: p53, Bcl-xL, Bax and Bak in gastric cancer cells in correlation with clinical and pathomorphological factors.
Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kamocki Z; Zaręba K; Kemona A; Kędra B
Adv Med Sci; 2012 Jun; 57(1):77-83. PubMed ID: 22440942
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
[TBL] [Abstract][Full Text] [Related]
12. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets.
Kodama T; Takehara T; Hikita H; Shimizu S; Shigekawa M; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Yin XM; Hayashi N
J Biol Chem; 2011 Apr; 286(16):13905-13. PubMed ID: 21367852
[TBL] [Abstract][Full Text] [Related]
13. Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis Pathway.
Miao W; Song B; Shi B; Wan Q; Lv Q; Chen H; Zhu M; Zhang L; Han Y; Wu D
Thromb Haemost; 2021 Apr; 121(4):495-505. PubMed ID: 33124021
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
15. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
17. Platelet apoptosis resistance and increased CXCR4 expression in pediatric patients with chronic immune thrombocytopenic purpura.
Wang JD; Ou TT; Wang CJ; Chang TK; Lee HJ
Thromb Res; 2010 Oct; 126(4):311-8. PubMed ID: 20708218
[TBL] [Abstract][Full Text] [Related]
18. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura.
Chang-Lin WU; Jian-Cheng XU; Fang LI; Hong XI; Xue-Min ZH; Qun CH; Xue-Wen LV
Int J Lab Hematol; 2007 Jun; 29(3):177-84. PubMed ID: 17474894
[TBL] [Abstract][Full Text] [Related]
19. Platelet antibodies, activated platelets and serum leptin in childhood immune thrombocytopenic purpura.
Badrawy H; Elsayh KI; Zahran AM; El-Ghazali MH
Acta Haematol; 2013; 130(4):312-8. PubMed ID: 24008828
[TBL] [Abstract][Full Text] [Related]
20. Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1).
Delbridge AR; Chappaz S; Ritchie ME; Kile BT; Strasser A; Grabow S
Br J Haematol; 2016 Sep; 174(6):962-9. PubMed ID: 27221652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
